作者：
Naipal,K.A.T. [1]
;
Verkaik,N.S. [2]
;
Ameziane,N. [3]
;
VanDeurzen,C.H.M. [4]
;
Brugge,P.T. [5]
;
Meijers,M. [6]
;
Sieuwerts,A.M. [7]
;
Martens,J.W. [8]
;
O'Connor,M.J. ;
Vrieling,H. ;
Hoeijmakers,J.H.J. ;
Jonkers,J. ;
Kanaar,R. ;
DeWinter,J.P. ;
Vreeswijk,M.P. ;
Jager,A. ;
VanGent,D.C.
作者单位：
AstraZeneca, IMed OncologyMacclesfield, Cheshire, United Kingdom
[1]
Department of Genetics, Erasmus University Medical Center, P.O. Box 2040Rotterdam, Netherlands
[2]
Department of Clinical Genetics, VU University Medical CenterAmsterdam, Netherlands
[3]
Division of Molecular Pathology, Netherlands Cancer InstituteAmsterdam, Netherlands
[4]
Department of Toxicogenetics, Leiden University Medical CenterLeiden, Netherlands
[5]
Department of Toxicogenetics, Leiden University Medical CenterLeiden, Netherlands, Department of
[6]
Department of Pathology, Erasmus University Medical CenterRotterdam, Netherlands
[7]
Department of Medical Oncology, Erasmus University Medical CenterRotterdam, Netherlands
[8]
发布时间
2015-02-03
换一批
